MAP2K7 and cancer: In the cancers of prostate, colon, lung, melanoma, and Ewing sarcoma, CAV1 has been shown to activate the RAS-ERK-MEK signalling and promote cancer progression50–54, demonstrating that in certain cancer tissue the role of CAV1 in this pathway is opposite as compared to mesothelial cells.